Yonghyo Kim
Daejeon, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Collagen I is the effective therapeutic target for treating desmoid tumors.
Journal: Anti-cancer drugs
Published: September 17, 2025
Melanoma Proteomics Unveiled: Harmonizing Diverse Data Sets for Biomarker Discovery and Clinical Insights via MEL-PLOT.
Journal: Journal of proteome research
Published: May 05, 2025
Chlorhexidine Dihydrochloride Shows Anti-tumor Effects in Desmoid Tumors and Colorectal Cancer.
Journal: Anticancer research
Published: October 27, 2024
Anti-tumor Effects of Idarubicin Hydrochloride in Desmoid Tumors.
Journal: Anticancer research
Published: October 10, 2024
Unbiased Drug Target Prediction Reveals Sensitivity to Ferroptosis Inducers, HDAC and RTK Inhibitors in Melanoma Subtypes.
Journal: International journal of dermatology
Published: October 02, 2024
Predicting immune checkpoint therapy response in three independent metastatic melanoma cohorts.
Journal: bioRxiv : the preprint server for biology
Published: May 15, 2024
Mitochondrial dysfunction and immune suppression in BRAF V600E-mutated metastatic melanoma.
Journal: Clinical and translational medicine
Published: May 07, 2024
Predicting immune checkpoint therapy response in three independent metastatic melanoma cohorts.
Journal: Frontiers in oncology
Published: May 05, 2024
Identifying Ferroptosis Inducers, HDAC, and RTK Inhibitor Sensitivity in Melanoma Subtypes through Unbiased Drug Target Prediction.
Journal: bioRxiv : the preprint server for biology
Published: March 28, 2024
The Significance of N6-Methyladenosine RNA Methylation in Regulating the Hepatitis B Virus Life Cycle.
Journal: Journal of microbiology and biotechnology
Published: September 08, 2023
API-2-Induced Cell Migration Is Overcome by Small Molecular Approaches Inhibiting β-Catenin.
Journal: Current issues in molecular biology
Published: September 05, 2022
Last Updated: 09/26/2026